We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
Cap. Flow
+$7.6B
Cap. Flow %
5.51%
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351

Sector Composition

Rank Sector Weight
1 Healthcare 12.22%
2 Technology 11.9%
3 Financials 9.98%
4 Consumer Discretionary 7.32%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBNC icon
3526
Horizon Bancorp
HBNC
$1.04B
$453K ﹤0.01%
23,849
-3,289
-12% -$60.3K
YORW icon
3527
York Water
YORW
$502M
$450K ﹤0.01%
9,764
-1,199
-11% -$52.6K
ETD icon
3528
Ethan Allen Interiors
ETD
$570M
$449K ﹤0.01%
23,600
-4,826
-17% -$89.9K
LMAT icon
3529
LeMaitre Vascular
LMAT
$2.32B
$449K ﹤0.01%
12,488
-987
-7% -$34.1K
CUBI icon
3530
Customers Bancorp
CUBI
$2.66B
$448K ﹤0.01%
18,789
-4,718
-20% -$108K
MOV icon
3531
Movado Group
MOV
$849M
$447K ﹤0.01%
20,576
+801
+4% +$18.7K
MTRX icon
3532
Matrix Service
MTRX
$326M
$447K ﹤0.01%
19,499
+2,903
+17% +$57.3K
CHNG
3533
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$446K ﹤0.01%
27,226
-46,590
-63% -$625K
SWI
3534
DELISTED
SolarWinds Corporation Common Stock
SWI
$446K ﹤0.01%
+22,769
New +$452K
FFG
3535
DELISTED
FBL Financial Group
FFG
$446K ﹤0.01%
7,560
-1,050
-12% -$60.4K
UTI icon
3536
Universal Technical Institute
UTI
$2.16B
$445K ﹤0.01%
+57,702
New +$348K
BCSF icon
3537
Bain Capital Specialty
BCSF
$806M
$444K ﹤0.01%
22,888
-129,352
-85% -$2.43M
VIVO
3538
DELISTED
Meridian Bioscience Inc
VIVO
$444K ﹤0.01%
45,361
+14,612
+48% +$137K
GFF icon
3539
Griffon
GFF
$3.95B
$443K ﹤0.01%
21,783
-8,617
-28% -$181K
GRC icon
3540
Gorman-Rupp
GRC
$2.14B
$443K ﹤0.01%
11,843
-399
-3% -$14.5K
AMRX icon
3541
Amneal Pharmaceuticals
AMRX
$5.85B
$441K ﹤0.01%
91,425
+31,675
+53% +$110K
ARCB icon
3542
ArcBest
ARCB
$3.23B
$440K ﹤0.01%
15,975
-5,728
-26% -$166K
INCO icon
3543
Columbia India Consumer ETF
INCO
$234M
$440K ﹤0.01%
10,423
-600
-5% -$25.3K
FBMS
3544
DELISTED
The First Bancshares, Inc.
FBMS
$440K ﹤0.01%
12,386
+1,619
+15% +$53.7K
EFNL icon
3545
iShares MSCI Finland ETF
EFNL
$244M
$438K ﹤0.01%
11,500
-2,294
-17% -$85.1K
IHRT icon
3546
iHeartMedia
IHRT
$543M
$438K ﹤0.01%
+25,884
New +$392K
DXPE icon
3547
DXP Enterprises
DXPE
$2.43B
$436K ﹤0.01%
10,958
-1,835
-14% -$68.4K
EMLP icon
3548
First Trust North American Energy Infrastructure Fund
EMLP
$4.11B
$436K ﹤0.01%
+17,100
New +$425K
PRTA icon
3549
Prothena Corp
PRTA
$425M
$434K ﹤0.01%
27,429
-1,533
-5% -$16.4K
TVRD
3550
Tvardi Therapeutics
TVRD
$19.7M
$433K ﹤0.01%
747
+7
+0.9% +$4.91K

Similar funds

Credit Suisse's Q4 2019 Portfolio in Review

As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.

  • Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
  • Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
  • Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
  • Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
  • Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
  • Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.

Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.